The impact of the COVID-19 pandemic on deal making in the first six months of 2020 was significant but not unexpected, yet regional differences in deal performance and volume revealed by M&A data from Willis Towers Watson have been more dramatic. Based on share price performance, the latest results from leading global advisory, broking and… Continue reading U.S. Q2 M&A Deals Hit by COVID-19